Delivery Order SPE2DB22D2005-SPE2DB24FJSZ1

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB22D3004|SPE2DB25FPT97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,513.11 firm fixed-price delivery order is for 4567459608 - ARIPIPRAZOLE 1 MG/ML SOLUTION 150ML, a psychiatric medication. The contract has a performance period through March 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, with ID SPE2DB20D7059|SPE2DB25FPZQ1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,227.25 firm fixed-price delivery order is for the supply of 4567177902 ARIPIPRAZOLE 10 MG TABLET 500S, with a period of performance through February 7, 2025. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order worth $11,557.54 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of 4564629710 - Aripiprazole 1 mg/ml Solution 150ml. The contract has an ultimate completion date of May 17, 2024 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is a firm fixed price delivery order for 4564161107 - ARIPIPRAZOLE 1 MG/ML SOLUTION 150ML, with a ceiling value of $3,701.55 and a performance period through April 4, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceuticals, medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,066.76 Firm Fixed Price Delivery Order covers the supply of ARIPIPRAZOLE 2 MG TABLET UD 30S, a prescription medication. The contract has an ultimate completion date of July 23, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Aripiprazole 1 mg/ml solution, a medication used to treat certain mental health conditions. The delivery order has a ceiling value of $4,640.81 and a period of performance through April 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Aripiprazole 5 mg tablets. The contract has a potential value of $1,745.77 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation associated with this award. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with DLA,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,347.67, is for the provision of 4567942975 ABILIFY MAINTENA ER 400 MG SYRS, a prescription medication. The contract has an ultimate completion date of April 17, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,765.38 with a firm fixed price pricing type. It is for the supply of ABILIFY ASIMTUFII 960 MG/3.2ML 3.2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 28, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,842.17 firm fixed-price delivery order is for the supply of ABILIFY MAINTENA ER 400 MG SYRS, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJSZ1
    Delivery Order

The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $1,516.26 firm fixed-price delivery order contract (SPE2DB22D2005|SPE2DB24FJSZ1) to provide 4565877402 - ARIPIPRAZOLE 1 MG/ML SOLUTION 150ML. This delivery order was placed under an existing Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently procure a wide range of essential pharmaceutical and medical supplies from Amerisourcebergen. The contract has no set-aside designation and has an ultimate completion date of September 20, 2024.

Generated 12/19/24, 9:15 AM